Tango Therapeutics EPS TNGX

Diluted earnings per share by quarter and over the last twelve months, from 2020.

Tango Therapeutics' earnings per share was −$0.85 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.37.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY26	Jun 30, 2026	−$0.37	n/a	−$0.85
Q1 FY26	Mar 31, 2026	−$0.32	n/a	−$0.83
Q4 FY25	Dec 31, 2025	−$0.29	n/a	−$0.87
Q3 FY25	Sep 30, 2025	$0.13	n/a	−$0.92
Q2 FY25	Jun 30, 2025	−$0.35	n/a	−$1.32
Q1 FY25	Mar 31, 2025	−$0.36	n/a	−$1.21
Q4 FY24	Dec 31, 2024	−$0.34	n/a	−$1.20
Q3 FY24	Sep 30, 2024	−$0.27	n/a	−$1.15
Q2 FY24	Jun 30, 2024	−$0.24	n/a	−$1.11
Q1 FY24	Mar 31, 2024	−$0.35	n/a	−$1.10
Q4 FY23	Dec 31, 2023	−$0.29	n/a	−$1.07
Q3 FY23	Sep 30, 2023	−$0.23	n/a	−$1.11

Companies in Drug Manufacturers - General nearest Tango Therapeutics' size, closest first, today.

Company	EPS, 12 months	Growth
TNGXTango Therapeutics	−$0.85
ARQTArcutis Biotherapeutics	$0.22
LQDALiquidia	$1.39
INDVIndivior Pharmaceuticals	$2.78	+227% a year
OGNOrganon	$0.77	−71% a year
NRIXNurix Therapeutics	$2.31
KNSAKiniksa Pharmaceuticals International	$0.97	+2325% a year
LGNDLigand Pharmaceuticals	$9.40
AMRXAmneal Pharmaceuticals	$0.49	+4800% a year
PBHPrestige Consumer Healthcare	$3.57	−16% a year
ALKSAlkermes plc.	$0.38	−82% a year
Peer median	$1.18